Gastroenterology
Volume 126, Issue 2 , Pages 451-459 , February 2004

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

  • Matthew Rutter

      Affiliations

    • Department of Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, Teesside, UK England
    • St. Mark’s Hospital, Harrow, London, UK England
    • Corresponding Author InformationAddress requests for reprints to: Matthew Rutter, MBBS, MRCP (UK), Department of Gastroenterology, University Hospital of North Tees, Stockton-on-Tees, Teesside TS19 8PE, UK England fax: (44) 0-1642-383289
    • ,
  • Brian Saunders

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Kay Wilkinson

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Steve Rumbles

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Gillian Schofield

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Michael Kamm

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Christopher Williams

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Ashley Price

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Ian Talbot

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England
    • ,
  • Alastair Forbes

      Affiliations

    • St. Mark’s Hospital, Harrow, London, UK England

Received 17 July 2003 ,Accepted 23 October 2003.

References 

  1. Rhodes JM. Unifying hypothesis for inflammatory bowel disease and associated colon cancer (sticking the pieces together with sugar). Lancet. 1996;347:40–44
  2. Shanahan F. Relation between colitis and colon cancer. Lancet. 2001;357:246–247
  3. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease (a population-based cohort study). Lancet. 2001;357:262–266
  4. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994;107:934–944
  5. Torres C, Antonioli D, Odze RD. Polypoid dysplasia and adenomas in inflammatory bowel disease (a clinical, pathologic, and follow-up study of 89 polyps from 59 patients). Am J Surg Pathol. 1998;22:275–284
  6. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999;117:1288–1294 discussion 1488–1491
  7. Rubin PH, Friedman S, Harpaz N, Goldstein E, Weiser J, Schiller J, et al. Colonoscopic polypectomy in chronic colitis (conservative management after endoscopic resection of dysplastic polyps). Gastroenterology. 1999;117:1295–1300
  8. Bernstein CN. ALMs versus DALMs in ulcerative colitis (polypectomy or colectomy?). Gastroenterology. 1999;117:1488–1492
  9. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis (A case-control study). Gastroenterology. 1989;97:255–259
  10. Motley RJ, Rhodes J, Williams G, Tavares IA, Bennett A. Smoking, eicosanoids and ulcerative colitis. J Pharm Pharmacol. 1990;42:288–289
  11. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer (IBD-associated and sporadic cancer compared). Trends Mol Med. 2002;8:10–16
  12. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356–1362
  13. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis: Part IV: carcinoma of the colon. Gut. 1964;5:15–22
  14. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO. Risk factors for colorectal cancer in patients with ulcerative colitis (a case-control study). Gastroenterology. 1994;107:117–120
  15. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis (a case-control study). Aliment Pharmacol Ther. 2000;14:145–153
  16. Gomes P, du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986;27:92–95
  17. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer (A population-based study). N Engl J Med. 1990;323:1228–1233
  18. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995;83:493–501
  19. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000;19:19–27
  20. Lindberg BU, Broome U, Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis: The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum. 2001;44:77–85
  21. Moody GA, Jayanthi V, Probert CS, Mac K, Mayberry JF. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis (a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire). Eur J Gastroenterol Hepatol. 1996;8:1179–1183
  22. Rubin G, Hungin AP, Chinn D, Dwarakanath AD, Green L, Bates J. Long-term aminosalicylate therapy is under-used in patients with ulcerative colitis (a cross-sectional survey). Aliment Pharmacol Ther. 2002;16:1889–1893
  23. Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis (fact or fiction?). Gut. 2001;48:430–434
  24. Broome U, Lindberg G, Lofberg R. Primary sclerosing cholangitis in ulcerative colitis—a risk factor for the development of dysplasia and DNA aneuploidy?. Gastroenterology. 1992;102:1877–1880
  25. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1996;110:331–338
  26. Giovannucci E, Colditz GA, Stampfer MJ, Hunter D, Rosner BA, Willett WC, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S women. J Natl Cancer Inst. 1994;86:192–199
  27. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S men. J Natl Cancer Inst. 1994;86:183–191
  28. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103:1444–1451
  29. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet. 1990;336:357–359

PII: S0016-5085(03)01791-8

doi: 10.1053/j.gastro.2003.11.010

Gastroenterology
Volume 126, Issue 2 , Pages 451-459 , February 2004

Article Tools